Nasal carriage of methicillin-resistant Staphylococcus aureus among patients with end-stage renal disease

Infection Control and Hospital Epidemiology

Volumn 30, Issue 1, 2009, Pages 93-94

  Wang, Cheng Yi ^a,b   Wu, Vin Cent ^a   Chen, Yung Ming ^a   Su, Chi Ting ^a   Wu, Kwan Dun ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; GENOTYPE; HEALTH CARE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; UNIVERSITY HOSPITAL;

CARRIER STATE; HUMANS; KIDNEY FAILURE, CHRONIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NASAL MUCOSA;

EID: 57749095049     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/592708     Document Type: Article

References (10)

1. Salzer W. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int 2005; 25:313-319.
2. D'Agata EM. Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 2002; 35:1212-1218.
3. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
4. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976-2984.
5. Johnson LB, Venugopal AA, Pawlak J, Saravolatz LD. Emergence of community-associated methicillin-resistant Staphylococcus aureus infection among patients with end-stage renal disease. Infect Control Hosp Epidemiol 2006; 27:1057-1062.
6. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 2007; 12:284-288.
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 17th informational supplement. Wayne, PA: CLSI; 2007:M100-S17.
8. Huang YH, Tseng SP, Hu JM, Tsai JC, Hsueh PR, Teng LJ. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect 2007; 13:717-724.
9. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113-5120.
10. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-4294.